BHST

BioHarvest Sciences Inc.

53
Fundamentals61/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential37/ 100

BHST's outlook is improving, though it still trails on the overall score.

VRT

Vertiv Holdings Co

87
Fundamentals85/ 100
Valuation87/ 100
Upside potential86/ 100
Risk potential19/ 100

VRT has the edge over BHST overall, supported by stronger valuation and stronger fundamentals.

BHST Fundamentals

MetricStatus
Stable
Under pressure
Weak
Unavailable

BHST's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

VRT Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

VRT's revenue, profitability, cash flow and balance sheet are all currently strong.

BHST PE Valuation

BHST has no meaningful PE right now: it lost money over the past year.

VRT PE Valuation

CHEAPFAIREXPENSIVE39x77x116x155x
CHEAPFAIREXPENSIVE39x77x116x155x
LevelPEPriceVs current
Forward23x$210—
Current39x$210—
Cheap58x$308+47%
Fair72x$383+83%
Expensive88x$472+125%

Historical ranges are pointers, not guarantees.

VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.

BHST Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Moderate

Analysts expect BHST's losses to shrink, with revenue growing.

VRT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for VRT, with profitability improving.

BHST Risk to reward

ScenarioChangePrice
Upside+59%$2.59
Downside-37%$1.03

Calculated from the latest close: $1.63 on Nov 12.

BHST trails VRT on modeled risk to reward, with less potential upside and more potential downside.

VRT Risk to reward

ScenarioChangePrice
Upside+122%$466.33
Downside-19%$169.11

Calculated from the latest close: $209.64 on Nov 12.

VRT has a better modeled risk to reward balance than BHST, with more potential upside and less potential downside.

BHST Earnings Per Share

Q3 2023: $-0.61Q4 2023: $-0.94Q1 2024: $-1.36Q2 2024: $-1.19Q3 2024: $-1.22Q4 2024: $-0.85Q1 2025: $-0.50Q2 2025: $-0.70Q3 2025: $-0.68Q4 2025: $-0.63Q1 2026: $-0.62Q2 2026: $-0.54
Q3 2023: $-0.61Q4 2023: $-0.94Q1 2024: $-1.36Q2 2024: $-1.19Q3 2024: $-1.22Q4 2024: $-0.85Q1 2025: $-0.50Q2 2025: $-0.70Q3 2025: $-0.68Q4 2025: $-0.63Q1 2026: $-0.62Q2 2026: $-0.54
QuarterTTM EPSYoY
Q2 2026-$0.54+$0.16
Q1 2026-$0.62-$0.12
Q4 2025-$0.63+$0.22
Q3 2025-$0.68+$0.54
Q2 2025-$0.70+$0.49
Q1 2025-$0.50+$0.86
Q4 2024-$0.85+$0.09
Q3 2024-$1.22-$0.61

BHST is still losing money, but far less than before: $0.54 per share over the past year, against $1.36 at its worst in early 2024.

VRT Earnings Per Share

Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
QuarterTTM EPSYoY
Forward$9.14+71%
Q3 2026$5.35+102%
Q2 2026$4.42+111%
Q1 2026$3.98+131%
Q4 2025$3.41+166%
Q3 2025$2.65+75%
Q2 2025$2.09+62%
Q1 2025$1.72+64%
Q4 2024$1.28+7.6%

VRT has the edge over BHST on earnings quality, reporting a profit while its opponent remains loss making.

BHST Quarterly Revenue

Q3 2023: $3MQ4 2023: $5MQ1 2024: $5MQ2 2024: $6MQ3 2024: $7MQ4 2024: $7MQ1 2025: $8MQ2 2025: $9MQ3 2025: $9MQ4 2025: $9MQ1 2026: $9MQ2 2026: $9M
Q3 2023: $3MQ4 2023: $5MQ1 2024: $5MQ2 2024: $6MQ3 2024: $7MQ4 2024: $7MQ1 2025: $8MQ2 2025: $9MQ3 2025: $9MQ4 2025: $9MQ1 2026: $9MQ2 2026: $9M
QuarterRevenueYoY
Q2 2026$8.8M+3.8%
Q1 2026$8.5M+8.2%
Q4 2025$9.1M+25%
Q3 2025$9.1M+39%
Q2 2025$8.5M+41%
Q1 2025$7.9M+47%
Q4 2024$7.3M+61%
Q3 2024$6.5M+102%

BHST has the edge over VRT on sales, with stronger typical year-over-year growth.

VRT Quarterly Revenue

Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
QuarterRevenueYoY
Q3 2026$4.3B+61%
Q2 2026$3.3B+24%
Q1 2026$2.6B+30%
Q4 2025$2.9B+23%
Q3 2025$2.7B+29%
Q2 2025$2.6B+35%
Q1 2025$2B+24%
Q4 2024$2.3B+26%

VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.

BHST Free Cash Flow

Q3 2023: −$1MQ4 2023: −$3MQ1 2024: −$2MQ2 2024: −$3MQ3 2024: −$2MQ4 2024: −$3MQ1 2025: −$2MQ2 2025: −$2MQ3 2025: −$3MQ4 2025: −$3MQ1 2026: −$2MQ2 2026: −$3M
Q3 2023: −$1MQ4 2023: −$3MQ1 2024: −$2MQ2 2024: −$3MQ3 2024: −$2MQ4 2024: −$3MQ1 2025: −$2MQ2 2025: −$2MQ3 2025: −$3MQ4 2025: −$3MQ1 2026: −$2MQ2 2026: −$3M
QuarterFree cash flowYoY
Q2 2026-$3.3M-$1.2M
Q1 2026-$2.2M-$59K
Q4 2025-$2.9M+$387.3K
Q3 2025-$2.5M-$270.7K
Q2 2025-$2.1M+$542.1K
Q1 2025-$2.1M-$311K
Q4 2024-$3.3M-$126.9K
Q3 2024-$2.3M-$836K

BHST has burned cash in almost every quarter: −$11M over the past year, against −$10M the year before.

VRT Free Cash Flow

Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
QuarterFree cash flowYoY
Q3 2026$654.9M+41%
Q2 2026$926.5M+233%
Q1 2026$654.2M+145%
Q4 2025$885.6M+143%
Q3 2025$463.5M+36%
Q2 2025$277.9M-19%
Q1 2025$266.8M+162%
Q4 2024$364.5M+18%

VRT has the edge over BHST on cash generation, producing positive trailing cash flow while its opponent burns cash.

BHST Total Shares

Q3 2023: 13MQ4 2023: 13MQ1 2024: 14MQ2 2024: 16MQ3 2024: 17MQ4 2024: 17MQ1 2025: 17MQ2 2025: 17MQ3 2025: 17MQ4 2025: 18MQ1 2026: 23MQ2 2026: 23M
Q3 2023: 13MQ4 2023: 13MQ1 2024: 14MQ2 2024: 16MQ3 2024: 17MQ4 2024: 17MQ1 2025: 17MQ2 2025: 17MQ3 2025: 17MQ4 2025: 18MQ1 2026: 23MQ2 2026: 23M
PeriodChange %Net change
Quarterly0%+477 shares
1 year+31%+5.3M shares
3 years+69%+9.2M shares
5 years+84%+10.3M shares
Available history+698%+19.8M shares

BHST has 23M diluted shares, up 31% from a year ago.

VRT Total Shares

Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
PeriodChange %Net change
Quarterly0%-64.9K shares
1 year+0.4%+1.8M shares
3 years+1.1%+4.4M shares
5 years+10%+36M shares
Available history+63%+152M shares

VRT has the edge over BHST on shareholder dilution, with a more favorable share count trend.

BHST Net Leverage

BHST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

VRT Net Leverage

Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 20260.1xVery low
Q1 20260.3xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.7xVery low
Q1 20250.8xVery low
Q4 20241.0xHealthy

VRT has more cash than debt.

BHST Weekly Momentum

MetricValueStatus
RSI32.6Neutral
Stochastic17.3Oversold

BHST's weekly RSI is 33 (neutral) and its Stochastic is 17 (oversold).

VRT Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic26.4Neutral

VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).

BHST PE vs Industrials Sector

BHST has no meaningful PE right now: it lost money over the past year.

VRT PE vs Industrials Sector

MetricVRTSector medianRelative
PE39x24x63% above
PE %35855 pts below

VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.

BHST Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.630% above
20 week MA$1.9717% below
50 week MA$3.4553% below
100 week MA$5.3069% below

VRT has stronger trend alignment. BHST is above 1 of 4 weekly averages versus VRT above 2 of 5.

VRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$221.85.5% below
20 week MA$254.418% below
50 week MA$253.917% below
100 week MA$189.111% above
200 week MA$123.570% above

VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.

BHST Yearly ROI

YearStart priceEnd priceROI
2024$4.80$6.15+28%
2025$6.15$5.33-13%
2026 YTD$5.33$1.63-69%

BHST has finished lower in one of the last two years. It's down 69% so far in 2026.

VRT Yearly ROI

YearStart priceEnd priceROI
2020$10.9$18.9+73%
2021$18.9$24.9+31%
2022$24.9$12.8-48%
2023$12.8$48.0+275%
2024$48.0$115.1+140%
2025$115.1$167.6+46%
2026 YTD$167.6$209.6+25%

VRT has the edge over BHST on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key